When Sipuleucel-T Should Be Used In Treatment Of mCRPC
Sumit K. Subudhi, MD, PhD, Assistant Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Discusses When Sipuleucel-...
Author: obr
Added: 03/20/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 20, 2019 Category: Cancer & Oncology Source Type: podcasts
Combining Checkpoint Inhibitors In mCRPC
Sumit K. Subudhi, MD, PhD, Assistant Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Discusses Combining Checkp...
Author: obr
Added: 03/20/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 20, 2019 Category: Cancer & Oncology Source Type: podcasts
The Outcomes Of The KEYNOTE 365 Study
Sumit K. Subudhi, MD, PhD, Assistant Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Discusses The Outcomes Of ...
Author: obr
Added: 03/20/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 20, 2019 Category: Cancer & Oncology Source Type: podcasts
The Challenges Using Biomarkers For Treatment Selection In Bladder Cancer
Yair Lotan, MD, Professor of Urology, Chief of Urologic Oncology, University of Texas Southwestern Medical Center, Discusses The Challenges Using Biomarkers For Treatment Selection In Bladder Cancer. ...
Author: obr
Added: 03/20/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 20, 2019 Category: Cancer & Oncology Source Type: podcasts
The Role Of Checkpoint Inhibitors In Bladder Cancer
Yair Lotan, MD, Professor of Urology, Chief of Urologic Oncology, University of Texas Southwestern Medical Center, Discusses The Role Of Checkpoint Inhibitors In Bladder Cancer. At The 2019 Genitourin...
Author: obr
Added: 03/20/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 20, 2019 Category: Cancer & Oncology Source Type: podcasts
Molecular Characterization & Subtyping Data In Bladder Cancer
Yair Lotan, MD, Professor of Urology, Chief of Urologic Oncology, University of Texas Southwestern Medical Center, Discusses Molecular Characterization & Subtyping Data In Bladder Cancer. At The 2019 ...
Author: obr
Added: 03/20/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 20, 2019 Category: Cancer & Oncology Source Type: podcasts
The Latest In Screening For High-Risk Asymptomatic Bladder Cancer
Yair Lotan, MD, Professor of Urology, Chief of Urologic Oncology, University of Texas Southwestern Medical Center, Discusses The Latest In Screening For High-Risk Asymptomatic Bladder Cancer. At The 2...
Author: obr
Added: 03/20/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 20, 2019 Category: Cancer & Oncology Source Type: podcasts
Outcomes Of KEYNOTE 057 In High-Risk Non-Muscle-Invasive Bladder Cancer
Yair Lotan, MD, Professor of Urology, Chief of Urologic Oncology, University of Texas Southwestern Medical Center, Discusses Outcomes Of KEYNOTE 057 In High-Risk Non-Muscle-Invasive Bladder Cancer. At...
Author: obr
Added: 03/20/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 20, 2019 Category: Cancer & Oncology Source Type: podcasts
Next Step In ZUMA Studies
Sattva Neelapu, M.D. Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX Discusses Next Step In ZUMA Studies At The 6...
Author: ASHReport
Added: 12/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - December 18, 2018 Category: Cancer & Oncology Source Type: podcasts
2 Year Update: ZUMA-1 Study
Sattva Neelapu, M.D. Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX Discusses 2 Year Update: ZUMA-1 Study At The...
Author: ASHReport
Added: 12/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - December 18, 2018 Category: Cancer & Oncology Source Type: podcasts
CheckMate 214 Retrospective Analyses
Nizar M. Tannir University of Texas MD Anderson Cancer Center, Houston, TX, USA discusses CheckMate 214 Retrospective Analyses From the Seventeenth International Kidney Cancer International Symposium ...
Author: kidneycancer
Added: 11/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 5, 2018 Category: Cancer & Oncology Source Type: podcasts
Analyzing Biological Data From The Genome Atlas
Pavlos Msaouel, MD, PhD Assistant Professor Genitourinary Medical Oncology The University of Texas MD Anderson Cancer Center discusses Analyzing Biological Data From The Genome Atlas. At Kidney Cancer...
Author: kidneycancer
Added: 10/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 11, 2018 Category: Cancer & Oncology Source Type: podcasts
Kidney Cancer Histology Variables
Pavlos Msaouel, MD, PhD Assistant Professor Genitourinary Medical Oncology The University of Texas MD Anderson Cancer Center discusses Kidney Cancer Histology Variables. At Kidney Cancer Association N...
Author: kidneycancer
Added: 10/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 11, 2018 Category: Cancer & Oncology Source Type: podcasts
Rare Kidney Cancer Treatments
Pavlos Msaouel, MD, PhD Assistant Professor Genitourinary Medical Oncology The University of Texas MD Anderson Cancer Center discusses Rare Kidney Cancer Treatments. At Kidney Cancer Association Natio...
Author: kidneycancer
Added: 10/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 11, 2018 Category: Cancer & Oncology Source Type: podcasts
Renal Medullary Carcinoma
Pavlos Msaouel, MD, PhD Assistant Professor Genitourinary Medical Oncology The University of Texas MD Anderson Cancer Center discusses Renal Medullary Carcinoma. At Kidney Cancer Association National ...
Author: kidneycancer
Added: 10/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 11, 2018 Category: Cancer & Oncology Source Type: podcasts
